BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 12429977)

  • 21. The FGF-related oncogene, K-FGF, maps to human chromosome region 11q13, possibly near int-2.
    Huebner K; Ferrari AC; Delli Bovi P; Croce CM; Basilico C
    Oncogene Res; 1988; 3(3):263-70. PubMed ID: 3060803
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails the bcl-1, int-2 and hst loci.
    Ali IU; Merlo G; Callahan R; Lidereau R
    Oncogene; 1989 Jan; 4(1):89-92. PubMed ID: 2915903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A region within murine chromosome 7F4, syntenic to the human 11q13 amplicon, is frequently amplified in 4NQO-induced oral cavity tumors.
    Yuan B; Oechsli MN; Hendler FJ
    Oncogene; 1997 Sep; 15(10):1161-70. PubMed ID: 9294609
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-2/Fgf-3 and hst/Fgf-4.
    Shackleford GM; MacArthur CA; Kwan HC; Varmus HE
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):740-4. PubMed ID: 8380647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D11S287, a putative oncogene on chromosome 11q13, is amplified and expressed in squamous cell and mammary carcinomas and linked to BCL-1.
    Lammie GA; Fantl V; Smith R; Schuuring E; Brookes S; Michalides R; Dickson C; Arnold A; Peters G
    Oncogene; 1991 Mar; 6(3):439-44. PubMed ID: 2011398
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amplification of the int-2 gene in primary human breast tumors.
    Lidereau R; Callahan R; Dickson C; Peters G; Escot C; Ali IU
    Oncogene Res; 1988 Feb; 2(3):285-91. PubMed ID: 2835739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cooperative induction of mammary tumorigenesis by TGFalpha and Wnts.
    Schroeder JA; Troyer KL; Lee DC
    Oncogene; 2000 Jun; 19(28):3193-9. PubMed ID: 10918574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FGF signaling inhibitor, SPRY4, is evolutionarily conserved target of WNT signaling pathway in progenitor cells.
    Katoh Y; Katoh M
    Int J Mol Med; 2006 Mar; 17(3):529-32. PubMed ID: 16465403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insertional mutagenesis identifies a member of the Wnt gene family as a candidate oncogene in the mammary epithelium of int-2/Fgf-3 transgenic mice.
    Lee FS; Lane TF; Kuo A; Shackleford GM; Leder P
    Proc Natl Acad Sci U S A; 1995 Mar; 92(6):2268-72. PubMed ID: 7892260
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Amplification and proviral activation of several Wnt genes during progression and clonal variation of mouse mammary tumors.
    Roelink H; Wagenaar E; Nusse R
    Oncogene; 1992 Mar; 7(3):487-92. PubMed ID: 1549363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Identification of a MMTV insertion mutation within the coding region of the Fgf-3 protooncogene.
    Morris DW; Dutra JC
    Virology; 1997 Nov; 238(1):161-5. PubMed ID: 9375020
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular cloning and chromosomal localization to 17q21 of the human WNT3 gene.
    Roelink H; Wang J; Black DM; Solomon E; Nusse R
    Genomics; 1993 Sep; 17(3):790-2. PubMed ID: 8244403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Deletion of 17p and amplification of the int-2 gene in esophageal carcinomas.
    Wagata T; Ishizaki K; Imamura M; Shimada Y; Ikenaga M; Tobe T
    Cancer Res; 1991 Apr; 51(8):2113-7. PubMed ID: 1826231
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antisense downregulation of a mouse mammary tumor virus activated protooncogene in mouse mammary tumor cells reverses the malignant phenotype.
    Li YX; Papkoff J; Sarkar NH
    Virology; 1999 Mar; 255(1):138-49. PubMed ID: 10049829
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The human int-1 gene is located at chromosome region 12q12-12q13 and is not rearranged in myxoid liposarcoma with t(12;16) (q13;p11).
    Turc-Carel C; Pietrzak E; Kakati S; Kinniburgh AJ; Sandberg AA
    Oncogene Res; 1987; 1(4):397-405. PubMed ID: 3329717
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BCL-1 participates in the 11q13 amplification found in breast cancer.
    Theillet C; Adnane J; Szepetowski P; Simon MP; Jeanteur P; Birnbaum D; Gaudray P
    Oncogene; 1990 Jan; 5(1):147-9. PubMed ID: 2181375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MMTV insertional mutagenesis identifies genes, gene families and pathways involved in mammary cancer.
    Theodorou V; Kimm MA; Boer M; Wessels L; Theelen W; Jonkers J; Hilkens J
    Nat Genet; 2007 Jun; 39(6):759-69. PubMed ID: 17468756
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative genomics on FGF16 orthologs.
    Katoh Y; Katoh M
    Int J Mol Med; 2005 Nov; 16(5):959-63. PubMed ID: 16211270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive genome and transcriptome analysis of the 11q13 amplicon in human oral cancer and synteny to the 7F5 amplicon in murine oral carcinoma.
    Huang X; Godfrey TE; Gooding WE; McCarty KS; Gollin SM
    Genes Chromosomes Cancer; 2006 Nov; 45(11):1058-69. PubMed ID: 16906560
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas.
    Theodorou V; Boer M; Weigelt B; Jonkers J; van der Valk M; Hilkens J
    Oncogene; 2004 Aug; 23(36):6047-55. PubMed ID: 15208658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.